Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) just unveiled an update.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has filed for the bankruptcy liquidation of its 55%-owned subsidiary, Tianjin Shin Poong Pharmaceutical Co., Ltd., due to the latter’s inability to repay its debts and insufficient assets to cover liabilities. This move is in accordance with the PRC Enterprise Bankruptcy Law and reflects the financial struggles faced by Shin Poong, which may impact the group’s operations and financial standing.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, is a company incorporated in the People’s Republic of China. The company operates in the pharmaceutical industry, focusing on the manufacturing, processing, and sale of pharmaceutical products such as tablets, capsules, and injectable preparations.
See more data about 2TZ stock on TipRanks’ Stock Analysis page.